Pharmafile Logo

Pepperl+Fuchs GB Limited

Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

77 Ripponden Road, Oldham, Lancashire, OL1 4EL, United Kingdom
+44 (0)161 6336431

 Latest Content from PMHub 

A guide to developing customer-centred, multichannel marketing

Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in...

A Pharma Marketer’s Guide to the Mobile Web

Despite an acknowledgement of the importance of mobile by the pharma sector, there has been little evidence to show that businesses are harnessing the mobile web effectively, instead opting for...

Marketing Automation for Pharma

With Pharma Marketers increasingly being asked to do more with fewer resources, Marketing Automation is a key area that needs to be explored. Find out how it could help you...

Blog the brand builder

This report looks into current practice in B2B marketing communications, the importance of online reputation, and the opportunities offered by social media. It confirms the move online and suggests that...

How to Master Multichannel Marketing in Pharma

Learn how to optimise your multichannel marketing for increased profitability and improved customer engagement.

Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…

Press Releases | May 30, 2011 | M3 (EU)

M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins as...